美国Genpathway 
Genpathway公司是市场上提供ChIP和DNA甲基化分析的领先者，并提供鉴定和分析转录因子和外界变化对基因的调控、基因转录和它们相关的信号通路的服务。这些Genpathway提供的分析和服务，可以帮助制药和生物技术公司来发现和检验新药、生物标记物和诊断试验，以及科研、政府研究院和农业公司。


Genpathway is an early-stage pharmacogenomics company that provides specialized drug and biomarker discovery services and develops novel diagnostic biomarkers that predict drug responses, enabling personalized treatments. The company applies its proprietary chromatin and methylated DNA immunoprecipitation sequencing (ChIP-Seq) technology to understand gene regulation and genetic pathways by studying transcription factor binding, gene transcription, and epigenetic events such as DNA methylation and histone modifications. Based on the information gained from its platform technology, Genpathway intends to develop and commercialize a broad portfolio of clinically validated molecular diagnostic products and services that will enable the accurate selection of specific drugs to efficaciously treat individuals with cancer, immune disorders, and other serious diseases.